Skip to main content
Cardiac Insight eyes $5.5M in additional funding, announces leadership changes
9/8/2017

Kirkland, Wash.-based Cardiac Insight is still seeking $5.5 million in a round of C-1 financing that recently generated $4.5 million to support sales, marketing and distribution of its Cardea Solo 7-day ECG sensor. The company also created a scientific advisory board, appointing former Heart Rhythm Society President Robert Hauser as chair, and also tapped OncoResponse CEO Clifford Stocks to serve on its board of directors.

Full Story: